- Home
- Â /Â Augmedix
Augmedix
Stock Price
$2.3
2024-10-02
Market Capitalization
$113.3 M
2024-08-26
Revenue
$44.9 M
FY, 2023
Augmedix Summary
Company Summary
- Overview
- Augmedix is a company that develops AI medical documentation products for physicians and hospitals. Its products include Augmedix Go, a clinician-controlled mobile app to create automated draft medical notes after each patient visit; Augmedix Prep, an AI-enabled chart preparation tool; Augmedix Go ED, a tool for emergency medicine that generates draft notes; etc.
- Type
- Public
- Status
- Active
- Founded
- 2012
- HQ
- San Francisco, CA, US | view all locations
- Website
- https://augmedix.com
- Cybersecurity rating
Table of Contents
Key People
Ian Shakil, Founder, Director, Chief Strategy Officer
Sandra Breber, Chief Operating Officer
Davin Lundquist, Chief Medical Officer
Operating MetricsView all
States
41
20.6%
FY, 2021
Average Annual Revenue per Clinician
$28K
3.8%
Q2, 2022
Dollar-Based Net Revenue Retention Rate
131.0%
1.6%
Q2, 2022
LocationsView all
2 locations detected
San Francisco, CAÂ HQ
United States
111 Sutter St., Suite 1300
Dhaka, Dhaka Division
Bangladesh
17c Panthapath
Augmedix Financials
Summary Financials
- Revenue (Q2, 2024)
- $13.7M
- Gross profit (Q2, 2024)
- $6.5M
- Net income (Q2, 2024)
- ($8.5M)
- Cash (Q2, 2024)
- $28.2M
- EBIT (Q2, 2024)
- ($8.7M)
- Enterprise value
- $88.5M